Orchid Chemicals, Pharmaceuticals Ltd clear USFDA inspection
Orchid Chemicals and Pharmaceuticals Ltd has said its Cephalosporin API manufacturing (antibiotic) complex in Alathur, Chennai, has successfully cleared the USFDA inspection.
“This test is conducted to show that our products and plant meet the required global standards,” the company spokesperson told ET. The facility has a capacity of 800 tonnes per annum. The oral and sterile Cephalosporin APIs produced here cater to developed markets such as the US, Europe and Japan.
This mandatory and routine test would enable Orchid continue with its supplies to those markets. At 13:41, shares of Orchid were up over 4% at Rs 243
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.